Cellular Source-Specific Effects of Apolipoprotein (Apo) E4 on Dendrite Arborization and Dendritic Spine Development

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Jain, Sachi ^a,c   Yoon, Seo Yeon ^a   Leung, Laura ^a,c   Knoferle, Johanna ^a,c   Huang, Yadong ^a,b,c,d  

^a GLADSTONE INSTITUTE OF NEUROLOGICAL DISEASE   (United States)

^b GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; GLIAL FIBRILLARY ACIDIC PROTEIN; NEURON SPECIFIC ENOLASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; AUDITORY CORTEX; CELL DENSITY; CELL LOSS; CELL STRUCTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DENDRITIC SPINE; ENTORHINAL CORTEX; FEMALE; MOUSE; NERVE CELL DIFFERENTIATION; NERVE CELL GROWTH; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ANALYSIS OF VARIANCE; ANIMALS; APOLIPOPROTEIN E4; ASTROCYTES; DENDRITES; DENDRITIC SPINES; ENTORHINAL CORTEX; FEMALE; GENE KNOCK-IN TECHNIQUES; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; MICE; MICE, TRANSGENIC; NEURONS;

EID: 84875111700     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059478     Document Type: Article

References (46)

1. Mahley RW, Weisgraber KH, Huang Y, (2006) Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc Natl Acad Sci U S A 103: 5644-5651.
2. Kim J, Basak JM, Holtzman DM, (2009) The role of apolipoprotein in Alzheimer's disease. Neuron 63: 287-303.
3. Huang YH, (2010) Aβ-independent roles of apolipoprotein E4 in the pathogenesis of Alzheimer's disease. Trends Mol Med 16: 287-294.
4. Huang Y, Mucke L, (2012) Alzheimer mechanisms and therapeutic strategies. Cell 148: 1204-1222.
5. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, et al. (1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A 90: 1977-1981.
6. Roses AD, (1996) Apolipoprotein E alleles as risk factors in Alzheimer's disease. Annu Rev Med 47: 387-400.
7. Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, et al. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923.
8. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, et al. (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. JAMA 278: 1349-1356.
9. Boschert U, Merlo-Pich E, Higgins G, Roses AD, Catsicas S, (1999) Apolipoprotein E expression by nerons surviving excitotoxic stress. Neurobiol Dis 6: 508-514.
10. Xu Q, Bernardo A, Walker D, Kanegawa T, Mahley RW, et al. (2006) Profile and regulation of apolipoprotein E (ApoE) expression in the CNS of mice with targeting of green fluorescent protein gene to the ApoE locus. J Neurosci 26: 4985-4994.
11. Xu Q, Walker D, Bernardo A, Brodbeck J, Balestra ME, et al. (2008) Intron-3 retention/splicing controls neuronal expression of apolipoprotein E in the CNS. J Neurosci 28: 1452-1459.
12. Chang S, Ma TR, Miranda RD, BAlestra ME, Mahley RW, Huang Y, (2005) Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity. Proc Natl Acad Sci USA. 102: 18694-18699.
13. Brecht WJ, Harris FM, Chang S, Tesseur I, Yu GQ, et al. (2004) Neuron-specific apolipoprotein E4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice. J Neurosci 24: 2527-2534.
14. Harris FM, Brecht WJ, Xu Q, Tesseur I, Kekonius L, et al. (2003) Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice. Proc Natl Acad Sci U S A 100: 10966-10971.
15. Buttini M, Masliah E, Yu GQ, Palop JJ, Chang S, et al. (2010) Cellular source of apolipoprotein E4 determines neuronal susceptibility to excitotoxic injury in transgenic mice. Am J Pathol 177: 563-569.
16. Raber J, Wong D, Buttini M, Orth M, Bellosta S, et al. (1998) Isoform-specific effects of human apolipoprotein E on brain function revealed in apoE knockout mice: increased susceptibility of females. Proc Natl Acad Sci U S A 95: 10914-10919.
17. Andrews-Zwilling Y, Bien-Ly N, Xu Q, Li G, Bernardo A, et al. (2010) Apolipoprotein E4 causes age-and Tau-dependent impairment of GABAergice interneurons, leading to learning and memory deficits in mice. J Neurosci 30: 13707-13717.
18. Hartman RE, Wozniak DF, Nardi A, Olney JW, Sartorius L, et al. (2001) Behavioral phenotyping of GFAP-apoE3 and-apoE4 transgenic mice: apoE4 mice show profound working memory impairments in the absence of Alzheimer's-like neuropathology. Exp Neurol 170: 326-344.
19. Masliah E, Mallory M, Alford M, DeTeresa R, Hansen LA, et al. (2001) Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease. Neurology 56: 127-129.
20. Baloyannis SJ, (2009) Dendritic pathology in Alzheimer's disease. J Neurol Sci 283: 153-157.
21. Nathan BP, Jiang Y, Wong GK, Shen F, Brewer GJ, et al. (2002) Apolipoprotein E4 inhibits, and apolipoprotein E3 promotes neurite outgrowth in cultured adult mouse cortical neurons through the low-density lipoprotein receptor-related protein. Brain Res 928: 96-105.
22. Bellosta S, Nathan BP, Orth M, Dong LM, Mahley RW, et al. (1995) Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cell produces differential effects on neurite outgrowth. J Biol Chem 270: 27063-27071.
23. Ji Y, Gong Y, Gan W, Beach T, Holtzman DM, et al. (2003) Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer's disease patients. Neuroscience 122: 305-315.
24. Brodbeck J, Balestra ME, Saunders AM, Roses AD, Mahley RW, et al. (2008) Rosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neurons. Proc Natl Acad Sci U S A 105: 1343-1346.
25. Brodbeck J, McGuire J, Liu Z, Meyer-Franke A, Balestra ME, et al. (2011) Structure-dependent impairment of intracellular apolipoprotein E4 trafficking and its detrimental effects are rescued by small-molecule structure correctors. J Biol Chem 286: 17217-17226.
26. Dumanis SB, Tesoriero JA, Babus LW, Nguyen MT, Trotter JH, et al. (2009) ApoE4 decreases spine density and dendritic complexity in cortical neurons in vivo. J Neurosci 29: 15317-15322.
27. Roses AD, Saunders AM, (2006) Perspective on a pathogenesis and treatment of Alzheimer's disease. Alzheimers Dement 2: 59-70.
28. Roses AD, (2010) An inherited variable Ploy-T repeat genotype in TOMM40 in Alzheimer Disease. Arch Neurol 67: 536-541.
29. Buttini M, Orth M, Bellosta S, Akeefe H, Pitas RE, et al. (1999) Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: isoform-specific effects on neurodegeneration. J Neurosci 19: 4867-4880.
30. Sullivan PM, Mace BE, Maeda N, Schmechel DE, (2004) Marked regional differences of brain human apolipoprotein E expression in targeted replacement mice. Neuroscience 124: 725-733.
31. Jain S, Yoon SY, Zhu L, Brodbeck J, Dai J, et al. (2012) Arf4 determines dentate gyrus-mediated pattern separation by regulating dendritic spine development. PLoS ONE 7: e46340.
32. Pool M, Thiemann J, Bar-Or A, Fournier AE, (2008) NeuriteTracer: a novel ImageJ plugin for automated quantification of neurite outgrowth. J Neurosci Methods 169: 134-139.
33. Vanderklish PW, Edelman GE, (2002) Dendritic spines elongate after stimulation of group 1 metabotropic glutamate receptors in cultured hippocampal neurons. Proc Natl Acad Sci U S A 99: 1639-1644.
34. Peebles CL, Yoo J, Thwin MT, Palop JJ, Noebels JL, et al. (2010) Arc regulates spine morphology and maintains network stability in vivo. Proc Natl Acad Sci U S A 107: 18173-18178.
35. Raber J, Wong D, Yu GQ, Buttini M, Mahley RW, et al. (2000) Apolipoprotein E and cognitive performance. Nature 404: 352-354.
36. Tada T, Sheng M, (2006) Molecular mechanisms of dendritic spine morphogenesis. Curr Opin Neurobiol 16: 95-101.
37. Teter B, Xu PT, Gilbert JR, Roses AD, Galasko D, et al. (1999) Human apolipoprotein E isoform-specific differences in neuronal sprouting in organotypic hippocampal culture. J Neurochem 73: 2613-2616.
38. Jaworski T, Lechat B, Demedts D, Gielis L, Devijver H, et al. (2011) Dendritic degeneration, neurovascular defects, and inflammation precede neuronal loss in a mouse model for tau-mediated neurodegeneration. Am J Pathol 179: 2001-2015.
39. Einstein G, Buranosky R, Crain BJ, (1994) Dendritic pathology of granule cells in Alzheimer's disease is unrelated to neuritic plaques. J Neurosci 14: 5077-5088.
40. Von Gunten A, Kovari E, Bussiere T, Rivara CB, Gold G, et al. (2006) Cognitive impact of neuronal pathology in the entorhinal cortex and CA1 field in Alzheimer's disease. Neurobiol Aging 27: 270-277.
41. DeKosky ST, Scheff SW, (1990) Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann Neurol 27: 457-464.
42. Bourne J, Harris KM, (2007) Do thin spines learn to be mushroom spines that remember? Curr Opin Neurobiol 17: 381-386.
43. Hoover BR, Reed MN, Su J, Penrod RD, Kotilinek LA, et al. (2010) Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron 68: 1067-1081.
44. Chen HK, Liu Z, Meyer-Franke A, Brodbeck J, Miranda RD, et al. (2012) Small molecule structure correctors abolish detrimental effects of apolipoprotein E4 in cultured neurons. J Biol Chem 287: 5253-5266.
45. Li Z, Okamoto K, Hayashi Y, Sheng M, (2004) The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 119: 873-887.
46. Caselli RJ, Dueck AC, Huentelman MJ, Lutz MW, Saunders AM, Reiman EM, et al. (2012) Longitudinal modeling of cognitive aging and the TOMM40 effect. Alzheimers Dement 8: 490-495.